BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 2564898)

  • 1. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates.
    Tersmette M; Gruters RA; de Wolf F; de Goede RE; Lange JM; Schellekens PT; Goudsmit J; Huisman HG; Miedema F
    J Virol; 1989 May; 63(5):2118-25. PubMed ID: 2564898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture.
    Schuitemaker H; Kootstra NA; de Goede RE; de Wolf F; Miedema F; Tersmette M
    J Virol; 1991 Jan; 65(1):356-63. PubMed ID: 1985204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.
    Tersmette M; de Goede RE; Al BJ; Winkel IN; Gruters RA; Cuypers HT; Huisman HG; Miedema F
    J Virol; 1988 Jun; 62(6):2026-32. PubMed ID: 3130494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression.
    Connor RI; Ho DD
    J Virol; 1994 Jul; 68(7):4400-8. PubMed ID: 7515972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality.
    Tersmette M; Lange JM; de Goede RE; de Wolf F; Eeftink-Schattenkerk JK; Schellekens PT; Coutinho RA; Huisman JG; Goudsmit J; Miedema F
    Lancet; 1989 May; 1(8645):983-5. PubMed ID: 2565516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course?
    Jurriaans S; Van Gemen B; Weverling GJ; Van Strijp D; Nara P; Coutinho R; Koot M; Schuitemaker H; Goudsmit J
    Virology; 1994 Oct; 204(1):223-33. PubMed ID: 7916514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syncytium induction in primary CD4+ T-cell lines from normal donors by human immunodeficiency virus type 1 isolates with non-syncytium-inducing genotype and phenotype in MT-2 cells.
    Todd BJ; Kedar P; Pope JH
    J Virol; 1995 Nov; 69(11):7099-105. PubMed ID: 7474129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus isolates from asymptomatic homosexual men and from AIDS patients have distinct biologic and genetic properties.
    Balachandran R; Thampatty P; Enrico A; Rinaldo C; Gupta P
    Virology; 1991 Jan; 180(1):229-38. PubMed ID: 1701946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.
    Koot M; Keet IP; Vos AH; de Goede RE; Roos MT; Coutinho RA; Miedema F; Schellekens PT; Tersmette M
    Ann Intern Med; 1993 May; 118(9):681-8. PubMed ID: 8096374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biphasic rate of CD4+ cell count decline during progression to AIDS correlates with HIV-1 phenotype.
    Schellekens PT; Tersmette M; Roos MT; Keet RP; de Wolf F; Coutinho RA; Miedema F
    AIDS; 1992 Jul; 6(7):665-9. PubMed ID: 1354447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population.
    Cornelissen M; Mulder-Kampinga G; Veenstra J; Zorgdrager F; Kuiken C; Hartman S; Dekker J; van der Hoek L; Sol C; Coutinho R
    J Virol; 1995 Mar; 69(3):1810-8. PubMed ID: 7853521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-syncytium-inducing HIV type 1 isolated from infected individuals replicates in MT-2 cells.
    Forte SE; Byron KS; Sullivan JL; Somasundaran M
    AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1613-8. PubMed ID: 7888220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophages and CD4+ T lymphocytes from two multiply exposed, uninfected individuals resist infection with primary non-syncytium-inducing isolates of human immunodeficiency virus type 1.
    Connor RI; Paxton WA; Sheridan KE; Koup RA
    J Virol; 1996 Dec; 70(12):8758-64. PubMed ID: 8971004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection.
    Nielsen C; Pedersen C; Lundgren JD; Gerstoft J
    AIDS; 1993 Aug; 7(8):1035-40. PubMed ID: 8104421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay.
    Koot M; Vos AH; Keet RP; de Goede RE; Dercksen MW; Terpstra FG; Coutinho RA; Miedema F; Tersmette M
    AIDS; 1992 Jan; 6(1):49-54. PubMed ID: 1543566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replicative characteristics of primary isolates of the human immunodeficiency virus type 1 in peripheral blood mononuclear cells, primary macrophages and CD4+ transformed T-cell lines.
    Jolly PE
    Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):1057-65. PubMed ID: 9449539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of syncytium-inducing and non-syncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection.
    van 't Wout AB; Blaak H; Ran LJ; Brouwer M; Kuiken C; Schuitemaker H
    J Virol; 1998 Jun; 72(6):5099-107. PubMed ID: 9573281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type 1 clones derived from a single individual.
    Groenink M; Fouchier RA; de Goede RE; de Wolf F; Gruters RA; Cuypers HT; Huisman HG; Tersmette M
    J Virol; 1991 Apr; 65(4):1968-75. PubMed ID: 2002552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype.
    Björndal A; Deng H; Jansson M; Fiore JR; Colognesi C; Karlsson A; Albert J; Scarlatti G; Littman DR; Fenyö EM
    J Virol; 1997 Oct; 71(10):7478-87. PubMed ID: 9311827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection with dual-tropic human immunodeficiency virus type 1 variants associated with rapid total T cell decline and disease progression in injection drug users.
    Yu XF; Wang Z; Vlahov D; Markham RB; Farzadegan H; Margolick JB
    J Infect Dis; 1998 Aug; 178(2):388-96. PubMed ID: 9697718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.